1. Home/
  2. Compounds/
  3. Bicalutamide



SourcesNames Used
GDSC1000, FIMMBicalutamide
PharmacoGx Bicalutamide

External IDs

Smiles: CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
Pubchem: 2375

Annotated Targets


Cell lines tested with Bicalutamide

1043 cell lines have been tested with this compound, using data from 2 dataset(s).
RMG-I ovary GDSC1000, FIMM3
KG-1 haematopoietic and lymphoid tissue GDSC1000, FIMM3
HDQ-P1 breast GDSC1000, FIMM3
MFM-223 breast GDSC1000, FIMM3
OVCAR-5 ovary GDSC1000, FIMM3
CAL-85-1 breast GDSC1000, FIMM3
K-562 haematopoietic and lymphoid tissue GDSC1000, FIMM3
MDA-MB-436 breast GDSC1000, FIMM3
Hs-578-T breast GDSC1000, FIMM3
ML-2 haematopoietic and lymphoid tissue GDSC1000, FIMM3
Download CSV
Download Data as CSV

Top molecular features associated with response to Bicalutamide

Feature TypeStandardized
Nominal ANOVA
mRNA TNKS FIMM AAC 0.63 4e-05
mRNA AP3S2 FIMM AAC 0.6 0.0002
mRNA C9orf16 FIMM AAC 0.53 0.0004
mRNA CDH9 FIMM AAC -0.54 0.0006
mRNA CYP4F3 FIMM AAC 0.53 0.0007
mRNA GJB5 FIMM AAC 0.54 0.0009
mRNA RAD23A FIMM AAC 0.51 0.001
mRNA ALDH3A1 FIMM AAC 0.5 0.001
mRNA KRT13 FIMM AAC 0.5 0.002
mRNA CSRP3 FIMM AAC 0.5 0.002
Download CSV